GlassScriptPhysician profile
William D Strickland
NPI 1013321546
$6,032.45
in general payments reported to CMS, 2019-2025
33 companies · $1,003 in 2025
The $1,003 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,457 · 2020: $256 · 2021: $30.34 · 2022: $831 · 2023: $1,207 · 2024: $1,248 · 2025: $1,003.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,458.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,016.85 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $813.68 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $641.95 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $512.76 | 2019-2025 | Vraylar, Qulipta |
| Pfizer INC. | $432.44 | 2019-2025 | |
| Glaxosmithkline, LLC. | $291.40 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $261.30 | 2019-2025 | Repatha, Otezla, Otezla |
| Novartis Pharmaceuticals Corporation | $203.38 | 2019-2025 | |
| Exact Sciences Corporation | $171.19 | 2023-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $168.80 | 2019-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Merck Sharp & Dohme LLC | $159.88 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Dexcom, INC. | $153.53 | 2022-2025 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $133.65 | 2022-2025 | Xifaxan, Trulance |
| Amarin Pharma, INC. | $121.15 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $109.51 | 2022-2024 |
Show all 33 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Strickland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.